GPC1 and pancreatic neoplasm: Among them, PD-L1 mediated tumor immune escape and immunotherapy resistance; Integrins promote specific metastasis of some tumors; GPC1, a biomarker of pancreatic cancer and CRC, accelerates the progression of CRC.